All posts by: Michael Zand

About Michael Zand

Stem cell summit brings top minds in regenerative medicine to Vail – Vail Daily News

Continue reading

2017-09-19 NEWS

Vail Daily News

Stem cell summit brings top minds in regenerative medicine to Vail
Vail Daily News
VAIL — Dr. Johnny Huard arrived at the Steadman Philippon Research Institute in 2015, and since then, the clinic’s annual Scientific Summit has become a showcase of what’s possible in the field of stem cell research. Huard is the chief scientific

and more »

Continue reading

2017-09-19 NEWS

Vail Daily News

Stem cell summit brings top minds in regenerative medicine to Vail
Vail Daily News
VAIL — Dr. Johnny Huard arrived at the Steadman Philippon Research Institute in 2015, and since then, the clinic’s annual Scientific Summit has become a showcase of what’s possible in the field of stem cell research. Huard is the chief scientific

Continue reading

2017-09-19 NEWS

Baltimore Business Journal

Md. stem cell company using $750000 to move toward commercialization, IPO
Baltimore Business Journal
… $750,000 in state funds to develop… more. Courtesy of TissueGene Inc. TissueGene Inc. was one of 29 entities to be awarded state funding through Maryland Technology Development Corp. to support research and development of stem cell therapies.

and more »

Continue reading

2017-09-19 NEWS

Baltimore Business Journal

Md. stem cell company using $750000 to move toward commercialization, IPO
Baltimore Business Journal
… $750,000 in state funds to develop… more. Courtesy of TissueGene Inc. TissueGene Inc. was one of 29 entities to be awarded state funding through Maryland Technology Development Corp. to support research and development of stem cell therapies.

and more »

Continue reading

2017-09-19 NEWS

SouthCoastToday.com

Fall River lab working on cutting-edge gene therapy
SouthCoastToday.com
FALL RIVER — A gene therapy treatment manufactured at MassBiologics in Fall River could soon improve quality of life for people with advanced Parkinson’s disease. The therapy is the first product to come out of the biological medicine laboratory’s

Continue reading

2017-09-19 NEWS

Winchester Herald Chronicle

UCSF First in State to Provide FDA-Approved CART for Pediatric Cancer Patients
UCSF News Services
CAR-T represents a radically different way of treating cancer. It entails filtering Tcells from the patient’s blood and reprogramming them to harbor a “chimeric antigen receptor,” or CAR, that zeroes in on cancer and develops millions of copies of the
Monroe Carell Jr. Children’s Hospital at Vanderbilt to offer new cutting-edge treatment for type of pediatric leukemiaWinchester Herald Chronicle

all 2 news articles »